CTXR: Citius Pharmaceuticals, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | 13G amendment | CVI Investments, Inc. | 9.90% | SEC |
Institutional ownership (Q2 2026)
42 institutions reported holding $809K of Citius Pharmaceuticals, Inc. on Form 13F (38 the quarter before). 12 opened a new position and 8 sold out. Shares held by institutions: +36%.
| Largest holders | Shares | Value |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 215,537 | $130K |
| VANGUARD CAPITAL MANAGEMENT LLC | 197,364 | $119K |
| Miller Financial Services LLC | 130,000 | $79K |
| CITADEL ADVISORS LLC | 124,910 | $76K |
| JANE STREET GROUP, LLC | 122,837 | $74K |
| VANGUARD FIDUCIARY TRUST CO | 77,755 | $47K |
| BlackRock, Inc. | 69,850 | $42K |
| NORTHERN TRUST CORP | 62,742 | $38K |
| XTX Topco Ltd | 59,199 | $36K |
| Asset Advisory Group, Inc. | 59,011 | $36K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.